Breaking News Instant updates and real-time market news.

2017-05-19 05:33:40 VRX Valeant $13.47 0.22 (1.66%) 05:33 05/19/17 05/19 05:33 05/19/17 05:33	Deutsche Bank 'warming up' to Valeant story In a research note titled "Warming up to VRX," Deutsche Bank analyst Gregg Gilbert says that while Valeant Pharmaceuticals is "not out of the woods," the worst fears may be subsiding. The analyst continues to view the company's near-term setup as "encouraging." Valeant's 2017 outlook seems reachable, asset sales in the near- and medium-term seem likely, and the recent refinancing provided more time and flexibility for the company to deal with its issues, Gilbert tells investors. He also believes the worst case for Xifaxan of near-term generic competition "seems to be off the table for now." The analyst keeps a Hold rating on Valeant with an $18 price target. The drugmaker closed yesterday up 22c to $13.47.	22 May 06 Jun 24 Aug
VRX Valeant $13.47 0.22 (1.66%) 04/21/17 WELS 04/21/17 NO CHANGE WELS Wells Fargo's Maris cuts Valeant price target range to $7-$9 Wells Fargo analyst David Maris cut his price target range for Valeant Pharmaceuticals to $7-$9 from $10-$13 and keeps an Underperform rating on the name. The drug maker closed yesterday down 14c to $8.88. Valeant shares are not worth the risk, Maris tells investors in a research note. He believes the company will not generate enough free cash flow between now and 2023 to pay its debt maturities. While Valeant's earnings may exceed near-term consensus estimates, investors have better opportunities elsewhere, Maris contends. 05/09/17 WELS 05/09/17 NO CHANGE WELS Underperform Valeant key products continue to underperform, says Wells Fargo Following the company's Q1 results, Wells Fargo analyst David Maris says Valeant Pharmaceuticals' key products continue to underperform. Valeant's decision to highlight in its press release the EBITDA raise of 1.3% is understandable, as this is better than the recent trend, but the $50M raise is relative to approximately $28.9B of total debt, Maris tells investors in a research note. Key products and areas such as Xifaxan and Bausch + Lomb continue to underperform, the analyst contends. He keeps an Underperform rating on Valeant with an $8 price target. The stock in morning trading is up 15%, or $1.48, to $11.19. 05/09/17 JPMS 05/09/17 NO CHANGE JPMS Neutral Valeant's road to recovery remains long, says JPMorgan JPMorgan analyst Chris Schott finds today's rally in Valeant Pharmaceuticals unsurprising as EBITDA guidance was raised following significant cuts over the past year. That said, the analyst continues to see a "long road to recovery for the story." He keeps a Neutral rating on the shares. Valeant is up 18%, or $1.79, to $11.50 in midday trading. 05/11/17 WELS 05/11/17 NO CHANGE Target $9 WELS Underperform Valeant estimates reduced on weakening fundamentals at Wells Fargo Wells Fargo analyst David Maris said the reaction to Valeant's guidance is too positive and notes leverage has increased, most businesses missed his forecasts, and the increase in EBITDA guidance was due to changes in how it accounts for foreign exchange. The analyst lowered estimates and reiterated his Underperform rating given the company's deteriorating fundamentals, adding that he expects the recent share strength to be temporary. However, he increased his price target on the shares to $9 from $8, noting Valeant's Q1 showed a "dramatic decline" in working capital.

2017-05-19 05:33:40

VRX

Valeant

$13.47: 0.22 (1.66%)

05:33

05/19/17

05/19

05:33

05/19/17

05:33

Deutsche Bank 'warming up' to Valeant story

In a research note titled "Warming up to VRX," Deutsche Bank analyst Gregg Gilbert says that while Valeant Pharmaceuticals is "not out of the woods," the worst fears may be subsiding. The analyst continues to view the company's near-term setup as "encouraging." Valeant's 2017 outlook seems reachable, asset sales in the near- and medium-term seem likely, and the recent refinancing provided more time and flexibility for the company to deal with its issues, Gilbert tells investors. He also believes the worst case for Xifaxan of near-term generic competition "seems to be off the table for now." The analyst keeps a Hold rating on Valeant with an $18 price target. The drugmaker closed yesterday up 22c to $13.47.

22
May
06
Jun
24
Aug

VRX Valeant

$13.47: 0.22 (1.66%)

04/21/17: WELS

05/09/17: WELS

05/09/17: JPMS

05/11/17: WELS

TODAY'S FREE FLY STORIES

CADE Cadence Bancorporation $22.32 0.03 (0.13%) 07:36 05/31/17 05/31 07:36 05/31/17 07:36 Initiation	Cadence Bancorporation initiated » Cadence Bancorporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CXRX Concordia $1.27 -0.025 (-1.94%) 07:36 05/31/17 05/31 07:36 05/31/17 07:36 Hot Stocks	Concordia: U.K. CMA intends to continue with pricing investigation » Concordia International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FOLD Amicus $7.66 -0.27 (-3.40%) 07:36 05/31/17 05/31 07:36 05/31/17 07:36 Hot Stocks	Amicus' SD-101 granted Rare Pediatric Disease designation » Amicus has received Rare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Jun
AAPL Apple $153.67 0.06 (0.04%) , NVDA Nvidia $144.87 3.03 (2.14%) … 07:35 05/31/17 05/31 07:35 05/31/17 07:35 Options	Unusual call flow in option market yesterday » Notable call activity was… AAPL Apple $153.67 0.06 (0.04%) NVDA Nvidia $144.87 3.03 (2.14%) BABA Alibaba $123.91 -0.08 (-0.06%) MU Micron $30.70 0.94 (3.16%) M Macy's $23.60 0.16 (0.68%) CSX CSX $54.22 0.26 (0.48%) KORS Michael Kors $36.27 -0.49 (-1.33%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 01 Jun 01 Jun 05 Jun 05 Jun 06 Jun 06 Jun 06 Jun 07 Jun 08 Jun 09 Jun 09 Jun 15 Jun 29 Jun
07:35 05/31/17 05/31 07:35 05/31/17 07:35 General news	FX Update: The dollar came under pressure » FX Update: The dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

CUI CUI Global $3.54 -0.11 (-3.01%) 07:35 05/31/17 05/31 07:35 05/31/17 07:35 Initiation	CUI Global initiated » CUI Global initiated with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 15 Jun
HLIT Harmonic $5.10 -0.15 (-2.86%) 07:34 05/31/17 05/31 07:34 05/31/17 07:34 Conference/Events	Harmonic management to meet with Drexel Hamilton » Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun
ALNY Alnylam $64.09 -1.71 (-2.60%) 07:34 05/31/17 05/31 07:34 05/31/17 07:34 Hot Stocks	FDA grants Breakthrough Therapy Designation for Alnylam's Givosiran » Alnylam Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Jun
DAKT Daktronics $9.28 0.14 (1.53%) 07:33 05/31/17 05/31 07:33 05/31/17 07:33 Earnings	Daktronics reports Q4 EPS 2c, consensus 6c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
EC Ecopetrol $9.36 -0.23 (-2.40%) 07:33 05/31/17 05/31 07:33 05/31/17 07:33 Downgrade	Ecopetrol rating change » Ecopetrol downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

DNKN Dunkin' Brands $58.32 0.15 (0.26%) 07:32 05/31/17 05/31 07:32 05/31/17 07:32 Hot Stocks	Dunkin' Brands names Kate Jaspon as CFO, effective June 5 » Dunkin' Brands Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Jun
EXAS Exact Sciences $32.65 -0.67 (-2.01%) , UNH UnitedHealth $176.59 -0.91 (-0.51%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Recommendations	Exact Sciences, UnitedHealth analyst commentary » Exact Sciences remains a… EXAS Exact Sciences $32.65 -0.67 (-2.01%) UNH UnitedHealth $176.59 -0.91 (-0.51%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 31 May 06 Jun
QCOM Qualcomm $57.34 -0.18 (-0.31%) , NXPI NXP Semiconductors $108.14 0.14 (0.13%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Hot Stocks	Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares » Qualcomm (QCOM) announced… QCOM Qualcomm $57.34 -0.18 (-0.31%) NXPI NXP Semiconductors $108.14 0.14 (0.13%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 09 Jun
FRO Frontline $5.41 -0.22 (-3.91%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Upgrade	Frontline rating change » Frontline upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EGHT 8x8, Inc. $13.60 0.1 (0.74%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Conference/Events	8x8, Inc. management to meet with Needham » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 01 Jun 06 Jun 06 Jun 08 Jun 13 Jun

GNRT Gener8 Maritime $4.91 0.06 (1.24%) , FRO Frontline $5.41 -0.22 (-3.91%) … 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Recommendations	Gener8 Maritime, Frontline, DHT Holdings analyst commentary » Gener8 Maritime advance… GNRT Gener8 Maritime $4.91 0.06 (1.24%) FRO Frontline $5.41 -0.22 (-3.91%) DHT DHT Holdings $4.20 -0.07 (-1.64%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WLL Whiting Petroleum $7.28 -0.69 (-8.66%) , ORCL Oracle $45.42 0.16 (0.35%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… WLL Whiting Petroleum $7.28 -0.69 (-8.66%) ORCL Oracle $45.42 0.16 (0.35%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:25 05/31/17 05/31 07:25 05/31/17 07:25 Technical Analysis	Technical View: Michael Kors drops to new 52-week low after earnings » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
CBS CBS $61.52 -0.05 (-0.08%) , CBS.A $63.50 -0.15 (-0.24%) … 07:24 05/31/17 05/31 07:24 05/31/17 07:24 Periodicals	Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says » CBS (CBS, CBS.A) news… CBS CBS $61.52 -0.05 (-0.08%) CBS.A $63.50 -0.15 (-0.24%) CMCSA Comcast $41.10 0.19 (0.46%) CMCSK Comcast DIS Disney $108.34 -0.07 (-0.06%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 08 Jun 15 Jun
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Hot Stocks	Breaking Hot Stocks news story on Michael Kors » Michael Kors drops 7% in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May

UAA Under Armour $19.56 -0.13 (-0.66%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Recommendations	Under Armour analyst commentary » Under Armour has reached… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
07:22 05/31/17 05/31 07:22 05/31/17 07:22 General news	Futures higher ahead of final trading for May » Stock futures are above… Stock futures are above fair value as the final trading session of May is set to begin. World markets closed trading with gains for the month as investors stateside will be looking ahead to Friday's nonfarm payrolls report. Today though they will see the Chicago purchasing manager's report and pending home sales data. The weekly oil numbers, which are normally released on Wednesday, will be delayed until tomorrow due to the Memorial Day holiday. In early trading, Dow futures are 18 points above fair value, Nasdaq futures are 12 points above fair value and S&P futures are 2 points above fair value.
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:22 05/31/17 05/31 07:22 05/31/17 07:22 Hot Stocks	Michael Kors says to close 100-125 full-price retail stores over next two years » Michael Kors announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
MYL Mylan $39.36 -0.36 (-0.91%) 07:19 05/31/17 05/31 07:19 05/31/17 07:19 Recommendations	Mylan analyst commentary » Pension fund campaign a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Sep 09 Oct
VIAB Viacom $35.05 -0.08 (-0.23%) , VIA Viacom $38.90 0.5 (1.30%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Recommendations	Viacom, Viacom analyst commentary » Viacom price target… VIAB Viacom $35.05 -0.08 (-0.23%) VIA Viacom $38.90 0.5 (1.30%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 08:00

Fed Bank President Kaplan Takes Part in a Discussion Government Event

New York, NY
JILL
Today at 08:00

J.Jill - JILL Conference Calls
KORS
Today at 08:00

Michael Kors - KORS Conference Calls
BWFG
Today at 08:00

Bankwell Financial Firm Sponsored Meetings

Woodway Country Club--540 Hoyt Street, Darien, CT
CUBE
Today at 08:00

CubeSmart Firm Sponsored Meetings

Co Offices--5 Old Lancaster Road, Malvern, PA
SCOR
Today at 08:30

comScore - SCOR Conference Calls
PRGO
Today at 08:30

Perrigo - PRGO Conference Calls
NVS
Today at 08:30

Novartis Firm Sponsored Meetings
ONCE
Today at 08:30

Spark Therapeutics Firm Sponsored Meetings

Offices of Ballard Spahr LLP--1735 Market Street, Philadelphia, PA
Today at 08:55

Redbook Store Sales Y/Y: Week 5/27 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ARI X ARI Apollo Commercial Spot Secondary Managers: Citi, JPMorgan, BofA/Merrill & Morgan Stanley $18.25-18.60 1.2M Shares JRVR X JRVR James River Group Spot Secondary Managers: Morgan Stanley $40.00-41.00 4.25M Shares STAY X STAY Extended Stay America Spot Secondary Managers: Morgan Stanley & Citi $17.50-17.60 2.5B Shares
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Deutsche Bank 'warming up' to Valeant story

TODAY'S FREE FLY STORIES

Get Full Fly Access